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Summary
Background.— Dilation of end-systolic and end-diastolic volumes (ESV, EDV) has been used to
deﬁne left ventricular remodelling after acute myocardial infarction (MI), but the prognostic
signiﬁcance of different enlargement patterns has not been evaluated fully.
Aim.— To analyse the evolution of left ventricular volumes and parameters of global and
regional contractility and their correlations with long-term prognosis in patients treated by
angioplasty in the acute phase of MI.
Methods.— Seventy-four patients (mean age 56± 13 years; 77% men), treated successfully by
angioplasty in the acute phase of MI, were included prospectively. Signiﬁcant enlargement of
left ventricular volumes was deﬁned as a greater than 20% increase between acute phase and
6-month control, assessed by contrast ventriculography. Clinical follow-up was obtained for all
patients at 82± 19months.
Results.— Four groups were identiﬁed based on volume evolution: Group I (n = 29, 39%; no
volume enlargement); Group II (n = 8, 11%; isolated EDV enlargement); Group III (n = 10, 14%;
isolated ESV enlargement); Group IV (n = 27, 36%; ESV plus EDV enlargement). Global left
ventricular ejection fraction increased in Groups I (p = 0.001) and II (p = 0.037), but decreased
Abbreviations: EDV, end-diastolic volume; ESV, end-systolic volume; MI, myocardial infarction; LV, left ventricular; LVEF, left
ventricular ejection fraction; RWMA, regional wall motion abnormalities.
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Conclusion.— Une augmentation du volume télésystolique après infarctus du myocarde chez
des patients traités par angioplastie à la phase aiguë a un impact négatif sur leur pronostic à
long terme, alors qu’une dilatation isolée du volume télédiastolique n’en a pas.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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yocardial infarction (MI) remains a leading cause of mor-
ality and morbidity in western countries. Patients who have
ad an MI have a 7- to 10-fold greater risk of develop-
ng heart failure compared with the normal population [1].
he development of clinically signiﬁcant heart failure is fre-
uently delayed, preceded by an asymptomatic phase during
hich LV volume enlargement is associated with changes in
ts shape [2]. The changes in ventricular topography, occur-
ing both acutely and chronically after MI, were attributed
o postinfarct remodelling in the 1990s and were identiﬁed
s an important prognostic variable [3]. The prevention or
eversal of LV remodelling has become one of the surro-
ate endpoints in the analysis of the efﬁcacy of different
herapeutic approaches, including reperfusion techniques
n the acute phase of MI, pharmacological treatment or,
ore recently, cell replacement therapy in the subacute or
hronic phase of ischaemic heart disease [4—7]. In different
eports dealing with the problem of LV remodelling, several
ndicators of LV function have been analysed: LVEF, RWMA,
phericity index, ESV, EDV [4,6,8—10]. Currently, there is
o consensus about the degree of LV enlargement neces-
ary to deﬁne clinically signiﬁcant remodelling, because of
he different imaging techniques used for analysis, with
heir inherent reproducibilities. Although ESV seems to be
he most powerful predictor of long-term prognosis [9,11],
he increase in EDV is used more frequently to deﬁne the
•
•emodelling [4,12—16]. Moreover, discrepancies between
hanges in global ejection fraction and in LV volume evo-
ution have been reported [15,17].
We sought to analyse the evolution of LV volume and the
arameters of global and regional contractility and their cor-
elations with long-term prognosis in a subset of patients
reated by angioplasty during the acute phase of MI.
ethods
tudy population
inety consecutive patients with acute MI who were hospi-
alized in our department between March 1997 and March
000 were included in this study. The inclusion criteria were
s follows:
ongoing MI conﬁrmed by typical chest pain for more than
20minutes associated with electrocardiogram changes
(ST-segment elevation in at least two consecutive leads
of greater than or equal to 1mm in limb leads or 2mm in
precordial leads);
admission within the ﬁrst 12 hours after the onset of chest
pain or within 24 hours if the pain persisted; successfulJ. Lipiecki et al.
in Groups III (p = 0.0002) and IV (p = 0.019). The 6-year event-free survival rate was signiﬁcantly
(p = 0.0039) better in Groups I and II (100%) than in Groups III and IV (80 and 78%, respectively).
Conclusion.— ESV enlargement in patients with reperfused acute MI impacts negatively on long-
term prognosis, while isolated EDV enlargement does not.
© 2009 Elsevier Masson SAS. All rights reserved.
Résumé
Introduction.— L’augmentation du volume télédiastolique et/ou du volume télésystolique du
ventricule gauche est habituellement utilisée pour déﬁnir le remodelage ventriculaire après
infarctus du myocarde Cependant, la valeur pronostique des différentes modalités de dilatation
du ventricule gauche n’a pas été complètement évaluée.
Méthodes.— Soixante-quatorze patients (âge moyen de 56± 13 ans, 77 % d’hommes) traités
par angioplastie à la phase aiguë d’un infarctus du myocarde ont été prospectivement inclus.
Une augmentation des volumes angiographiques était déﬁnie comme signiﬁcative si elle était
supérieure ou égale à 20% entre la phase aiguë et le contrôle au sixième mois. Le suivi clinique
a été obtenu pour tous les patients à 82± 19mois.
Résultats.— Quatre groupes de patients ont été individualisés en fonction de l’évolution des
volumes : groupe I (n = 29, 39 %) sans dilatation ventriculaire, groupe II (n = 8, 11 %) avec une
augmentation isolée du volume télédiastolique, groupe III (n = 10, 14 %) avec une augmentation
isolée du volume télésystolique, et IV (n = 27, 36 %) avec augmentation des volumes télédias-
toliques et télésystoliques. La fraction d’éjection globale du ventricule gauche augmentait dans
le groupe I (p = 0,001) et II (p = 0,037) alors qu’elle diminuait dans le groupe III (p = 0,0002) et IV
(p = 0,019). À six ans, le taux de survie sans évènement était signiﬁcativement supérieur dans les
groupes I et II (100 %) par rapport aux groupes III et IV (80 et 78 % respectivement, p = 0,0039).angioplasty procedure deﬁned as residual stenosis less
than 30% and TIMI ﬂow score 2 or 3;
stable sinus rhythm;
absence of bundle branch block;
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• stable haemodynamic conditions, deﬁned as Killip class
less than 3.
Routine contrast digital ventriculography was performed
immediately after the emergency angioplasty. According to
the policy of our department, control coronary ventricu-
lography was proposed at this stage to all patients treated
by angioplasty in the acute phase of MI. The rationale for
this approach was the search for occult restenosis of the
culprit artery, which occurs frequently and can alter the
functional recovery of partially infarcted myocardium [18].
Non-invasive tests for the detection of myocardial ischaemia
produce disappointing results in this patient population
[19,20]. This study was conducted according to the prin-
ciples outlined in the Declaration of Helsinki and informed
consent was obtained from all patients.
Acquisition and analysis of contrast digital
ventriculograms
Contrast digital ventriculography was obtained in the acute
phase and at 6-month control under the same technical con-
ditions. A 30mm steel sphere was placed on the lateral wall
of the chest at the level of the tip of the ‘‘pig tail’’ catheter
in the left lateral view and ﬁlmed in right oblique view at
30◦. The non-ionic contrast dye was injected by a power
injector (0.5mL/kg of body mass at the rate of 10mL/sec).
Images were stored in digital form for ofﬂine analysis using
dedicated software (Sanders Medical Data, San Francisco,
CA, USA). The EDV and ESV were calculated using the area-
length method and the RWMA index was calculated using
the centerline method, as described by Sheehan et al.
[21]. The software allows also the calculation of global
LVEF and the contractility index in the wall opposite the
necrosis. Signiﬁcant enlargement of LV volume was deﬁned
as a greater than or equal to 20% increase between the
acute phase and 6-month control, as proposed by Bolognese
et al. [4].
Long-term clinical follow-up
Major cardiac adverse events were deﬁned as cardiac death,
heart transplantation and hospitalization for overt heart
failure or life-threatening ventricular arrhythmias. After
hospital discharge, patients were referred to their usual car-
diologist and/or general practitioner. Follow-up data were
collected by telephone interview with patients, their rela-
tives and/or physicians.
Statistical analysis
Continuous variables are expressed as mean± standard devi-
ation. Comparisons of numerical data within groups were
carried out using Student’s t test for paired data. Com-
parisons between groups were performed using one-way
analysis of variance and Newman-Keuls tests. Qualitative
data were compared using the chi-square test with Yates’s
correction or Fisher’s exact test. Event-free survival curves
were constructed using the Kaplan-Meier method and sta-
tistical differences between curves were assessed by the
log-rank test. All tests were two-tailed and a p-value less
than 5% was considered to be signiﬁcant. All computations
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ere performed using the SAS statistical software package,
elease 8.02 (SAS Institute, Cary, NC, USA).
esults
f the 90 patients included in this study, 11 (12%) were
xcluded because of insufﬁcient quality of angiographic
mages and ﬁve (5.5%) refused control coronary angiogra-
hy. The ﬁnal study population consisted of 74 patients,
ho were predominantly men (77%) and relatively young
mean age 56± 13 years). Five patients had a history of
revious MI and three had undergone another angioplasty
rocedure. The electrocardiogram location of the MI was
nterior in 26 (35%) patients, inferior in 44 (59%) patients
nd lateral in four (6%) patients. Prehospital ﬁbrinolysis
as administered in seven (9%) patients and glycoprotein
Ib/IIIa antagonists were used during or immediately after
he angioplasty procedure in 12 (16%) patients. At hospi-
al discharge, all patients received conventional treatment
ncluding aspirin and ticlopidine (100%), betablockers (93%),
tatins (57%) and angiotensin-converting enzyme inhibitors
42%).
The ﬁnal study population of 74 patients were grouped
s follows:
absence of LV volume enlargement (n = 29, 39%; Group I);
isolated enlargement of EDV (n = 8, 11%; Group II);
isolated enlargement of ESV (n = 10, 14%; Group III);
increase in both EDV and ESV (n = 27, 36%; Group IV).
All groups were similar in terms of their clinical vari-
bles except for the use of glycoprotein IIb/IIIa antagonists
nd the peak of creatine kinase release, which were bor-
erline statistically signiﬁcantly different (Table 1). Groups
II and IV with ESV enlargement had a signiﬁcantly higher
eak creatine kinase release than Groups I and II without ESV
nlargement (2995± 1760 IU/L vs 2032± 1440 IU/L, respec-
ively; p = 0.009) and a lower use of glycoprotein IIb/IIIa
nhibitors (9% vs 33%, respectively; p = 0.016).
Among the angiographic variables, total occlusion of
nfarct-related artery with TIMI ﬂow grade 0—1 before
ngioplasty was seen more often in Groups III and IV
ith ESV dilation than in Groups I and II without ESV
ilation (95% vs 76%, respectively; p < 0.05), while the
ifference in minimal lumen diameter was of borderline sig-
iﬁcance (0.05± 0.23mm vs 0.18± 0.33mm, respectively;
= 0.06). No difference was seen between angiographic vari-
bles immediately after angioplasty or at 6-month control
xcept minimal luminal diameter of culprit lesion imme-
iately after angioplasty, which was signiﬁcantly higher
n Group II compared with the other groups (p = 0.048;
able 2). The 6-month restenosis rate was 25% in Group
, 0% in Group II, 10% in Group III and 24% in Group IV
p = 0.50). All patients with restenosis greater than 50% were
reated by another angioplasty during the control coronary
ngiography.volution of LV volume and contractility
etween the acute phase and 6-month control
he evolution of LV volume and contractility between the
cute phase and 6-month control is depicted in Fig. 1.
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Table 1 Clinical characteristics of the patients.
Group I (n = 29) Group II (n = 8) Group III (n = 10) Group IV (n = 27) p
Age (years)a 56.0± 13.4 53.1± 12.6 57.2± 10.2 58.0± 16.6 0.81
Men (%) 76 75 90 74 0.81
Location of myocardial infarction (%)
Anterior 34.4 37.5 30.0 37.0 0.96
Inferior 55.2 62.5 70.0 59.3
Lateral 10.3 0 0 3.7
Previous myocardial infarction (%) 0 12.5 0 11.1 0.14
Unstable angina (%)b 51.7 50.0 20.0 37.0 0.32
Glycoprotein IIb/IIIa antagonists (%) 40.0 14.3 10.0 8.3 0.057
Fibrinolysis (%) 15.0 0 0 14.8 0.58
Peak of creatine kinase release (IU/L)a 1860± 1248 2459± 2117 2883± 1410 3037± 1896 0.054
a Mean± standard deviation.
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4b Present in the 48 hours before index hospitalization.
hen Groups I and II without ESV dilation were compared
ith Groups III and IV with ESV dilation, there was a bor-
erline difference in EDV in the acute phase (122± 30mL
s 108± 28mL, respectively; p = 0.045), while at 6-month
ontrol this ratio was reversed, with a larger difference
124± 30mL vs 148± 39mL, respectively; p = 0.005).
Global LVEF increased in Group I (from 57± 11% to
2± 8%; p = 0.001) and in Group II (from 49± 13% to 63± 9%;
w
p
p
e
Table 2 Angiographic data during acute phase and 6-month c
Group I (n = 29) Grou
Acute phase
Before PTCA
Reference diameter (mm) 2.97± 0.62 2.84
MLD (mm) 0.18± 0.28 0.22
Total occlusion (%) 66.0 75.0
TIMI ﬂow (%)
0—1 72.4 87.5
2—3 27.6 12.5
Rentrop classa (%)
0—1 79.0 87.0
2—3 21.0 13.0
TIMI 2—3 and/or Rentrop 2—3 (%) 21.0 12.0
After PTCA
Reference diameter (mm) 3.04± 0.54 3.54
MLD (mm) 2.45± 0.75 3.20
Residual stenosis (%) 18.97± 19.2 9.39
TIMI ﬂow (%)
0—1 3.4 0
2—3 96.6 100
6-month control
Reference diameter (mm) 2.85± 061 3.18
MLD (mm) 1.85± 0.70 2.42
Stenosis (%) 36.0± 19.15 25.0
50% restenosis rate (%) 25.0 0
Total reocclusion rate (%) 0 0
MLD: minimal luminal diameter; PTCA: percutaneous transluminal coro
a Collateral circulation assessment using Rentrop classiﬁcation.= 0.037), but decreased in Group III (from 65± 11% to
2± 9%; p = 0.0002) and in Group IV (from 55± 12% to
9± 11%; p = 0.019). Similar differences were observed
hen groups with and without ESV enlargement were com-
ared.
RWMA indexes were similar in all groups in the acute
hase. In contrast, at 6-month control, a signiﬁcant recov-
ry of RWMA was observed in Group I (from —2.90± 1.42
ontrol contrast coronary angiography.
p II (n = 8) Group III (n = 10) Group IV (n = 27) p
± 0.65 2.92± 0.58 2.96± 0.62 0.97
± 0.57 0.00± 0.00 0.07± 0.27 0.26
100 85.0 0.09
100 92.6 0.096
0 7.4
80.0 93.0 0.49
20.0 7.0
20.0 7.0 0.49
± 0.21 3.15± 0.47 3.11± 0.65 0.22
± 0.33 2.60± 0.41 2.56± 0.57 0.048
± 8.88 16.75± 7.95 17.0± 12.30 0.51
0 0 1.00
100 100
± 031 3.06± 0.51 3.18± 0.68 0.24
± 0.75 2.11± 0.61 1.91± 0.92 0.33
± 16.73 31.2± 15.46 40.4± 25.27 0.32
10.0 24.0 0.50
0 7.0 0.56
nary angioplasty; TIMI: thrombolysis in myocardial infarction.
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Figure 1. Six-month evolution of LV volumes (a and b), global LVEF (c), RWMA in the territory of infarct-related artery (d) and compensatory
hyperkinesis in the territory opposite to the infarct (e). The basal EDV, global LVEF and compensatory hyperkinesis values were statistically
different between groups (p = 0.003, p = 0.029 and p = 0.01, respectively). The control EDV, ESV, RWMA and LVEF values were statistically
1, res
L
C
m
t
c
rdifferent between groups (p = 0.002, p < 0.0001, p < 0.0001, p < 0.00
S.D. to —1.32± 1.25 S.D.; p≤ 0.0001) and Group II (from
—3.39± 0.59 S.D. to —1.03± 0.93 SD; p = 0.0002) but not
in Group III (from —2.37± 1.04 S.D. to —2.67± 1.03
S.D.; p = 0.25) and Group IV (—3.01± 1.14 S.D. to
—2.92± 1.02 S.D.; p = 0.68). Compensatory hyperkine-
sis in the myocardial region opposite the infarction was
statistically more important in the acute phase in Groups
III and IV (2.45± 1.08 S.D. and 2.06± 1.47 S.D., respec-
tively) compared with Groups I and II (1.15± 1.43 S.D.
and 0.87± 1.23 S.D., respectively; p = 0.001 between
groups). This difference disappeared at 6-month
control.
i
r
p
spectively).
ong-term follow-up
linical follow-up was obtained for all patients at 82± 19
onths. The overall six-year clinical event rate was 30%. The
otal ischaemia-driven revascularization rate at 6-month
ontrol was 13.5% (14%, 13%, 0% and 15% in Groups I—IV,
espectively; p = 0.8). Three patients died from cancer dur-
ng long-term follow-up (one each in Groups I, III and IV).
During long-term follow-up, eight (11%) patients expe-
ienced a predeﬁned major adverse cardiac event. Four
atients died from cardiac causes (three from progres-
ive heart failure and one from sudden cardiac death); all
604
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iigure 2. Kaplan-Meier plot of event-free survival. Log-rank anal-
sis at three and six years. p = 0.47 and 0.039, respectively.
resented with simultaneous enlargement of ESV and EDV at
ix months (Group IV). Another two patients from this group
resented with ventricular arrhythmias and were implanted
ith an implantable deﬁbrillator. Two patients from Group
II were hospitalized for worsening of dyspnoea (New York
eart Association class IV); one was treated further by heart
ransplantation. At six years, the major adverse cardiac
vent-free survival rate was signiﬁcantly better in Groups
and II (100%) than in Groups III and IV (80 and 78%,
espectively, p = 0.0039 vs Groups I and II). The difference
n event-free survival between groups became statistically
igniﬁcant after three years of follow-up (Fig. 2).
iscussion
V remodelling can be considered to be both an adaptive
nd a maladaptive process, with the adaptive component
nabling the heart to maintain function in response to
yocardial insult in the acute phase of cardiac injury. To
ate, however, there are no data to indicate when the
ransition from possible adaptive to maladaptive remod-
lling occurs or how this might be evaluated in patients
22]. Our results suggest that visualization of isolated EDV
nlargement between the acute phase and six months after
reperfusion could serve as an indicator of such an adaptive
echanism. In our study, patients with isolated EDV enlarge-
ent and those with no volume enlargement had a similar
volution pattern with regard to RWMA, contractility in the
pposite wall to the infarction and global LVEF; patients with
his pattern had small enzymatic infarct size and normalized
lobal LVEF at six months, associated with the recovery of
WMA in the infarct territory. Similar ﬁndings with magnetic
esonance imaging have been reported by Fieno et al. [23]
n an animal model of MI and by Kramer et al. [17] in a clin-
cal study of patients treated by angioplasty in the acute
hase of MI. We have also shown that a relatively small ini-
ial EDV is predictive of further remodelling — a ﬁnding that
as been observed previously in larger studies [4,15]. How-
ver, in contrast to these two studies, we did not ﬁnd a
ifference in the RWMA index in the acute phase between
roups with and without remodelling; this could be related
o the use of different techniques for its assessment (the
emiquantitative score obtained by echocardiography and
he quantitative centerline method used in our work).
More importantly, the long-term prognosis of patients
ith isolated EDV enlargement was excellent in our study.
ne explanation might be that the LV volume overload that
t
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ccurs after MI increases end-diastolic stress which causes
he laying down of new sarcomeres at the end of individ-
al myocytes. Longer myocardial ﬁbres result in increased
V end-diastolic chamber size. The resulting larger EDV can
ccommodate the volume overload with a smaller (or no)
ncrease in end-diastolic pressure [24]. Unfortunately, only
few patients in our study (11%) showed such an isolated
DV enlargement. In contrast, ESV enlargement (isolated or
ssociated with EDV enlargement), which was observed in
0% of patients in this study, is associated with a completely
ifferent evolution of regional and global LV contractility.
SV enlargement is associated at six months with a fall in
lobal LVEF, absence of recovery of RWMA and a dramatic
ecrease in compensatory hyperkinesis in the opposite wall,
articularly if both volumes dilate. The event-free survival
t six years is signiﬁcantly worse than in patients without ESV
nlargement. ESV has been shown to be the variable that is
ost predictive of long-term prognosis, both in patients in
he prereperfusion era [9] and in those treated by reper-
usion therapy [4]. Moreover, signiﬁcant ESV enlargement
mpedes functional recovery after bypass surgery, even in
he presence of a substantial amount of viable myocardium
25]. A lack of recovery gives those patients a poor long-term
rognosis [26]. Taken together, all these data indicate that
SV rather than EDV evolution should be used as a marker
f ischaemic heart disease evolution and eventually serve as
surrogate endpoint for the comparison of different thera-
eutic approaches.
Despite the predominant inferior infarct location in this
tudy, the observed LV volume enlargement rate is one
f the highest compared with data published previously
4,12,15,16]. This observation can be explained in part
y the low rate of prescription of angiotensin-converting
nzyme inhibitors at discharge from initial hospitalization in
hese supposedly low-risk patients. The 36% rate of simul-
aneous EDV and ESV enlargement is very similar to that
bserved in the echo substudy of the third Gruppo Italiano
er lo Studio della Sopravvivenza nell’Infarto Miocardico
tudy (GISSI-3) (19% for early dilation and 16% for late dila-
ion), where the angiotensin-converting enzyme inhibitor
isinopril was used in 50% of patients. Additionally, our
esults suggest that LV remodelling should also be evaluated
n patients with non-anterior infarct location.
tudy limitations
he main limitation of our study was the small sample size,
o our results need to be conﬁrmed by a larger-scale study.
urthermore, functional patient assessment was not done
uring long-term follow-up, which could have given addi-
ional insights into their evolution. We did not perform a
erial assessment of LV volumes and contractility, unlike
olognese et al. [4] and Giannuzzi et al. [15]. Contrary to
hese two studies, in which echographic assessment of LV
unction was performed, our analysis was based on contrast
entriculography, which cannot be repeated serially due to
ts invasive character. Another limitation of our study was
he use of contrast angiography for LV volume assessment.
magnetic resonance imaging approach would have been
ore precise but this technique was not at our disposal
uring the inclusion period of our study. Finally, the LV end-
iastolic pressure was not recorded systematically during
[[
[
[
[
[
[
[
[
[
[
[
[
[Long-term prognosis after left ventricular enlargement
the acute phase intervention, so we were unable to analyse
the eventual predictive character of this variable.
Conclusions
Our study stresses the long-term clinical impact of ESV dila-
tion after acute MI. ESV enlargement of 20% or greater
corresponds better to the deﬁnition of LV remodelling than
EDV enlargement. EDV dilation can accompany ESV dilation
or be a compensatory mechanism associated with the recov-
ery of global and regional LV contractility.
Conﬂicts of interest
None.
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